Fully Covered WallFlex Biliary  RX Stent for Benign Indication

Fully Covered WallFlex™ Biliary RX Stent for Benign Indication

In an interim report from a prospective, multinational study presented at DDW 2013, endoscopic removal of the WallFlex Biliary Fully Covered Stent after up to one year of indwell in benign biliary strictures (BBS) was possible with an acceptable complication profile. All stents were able to be removed endoscopically (154). With mean follow-up to date of 569 days (+/- 103), there was overall stricture resolution in 76% of patients, including 80% in patients with BBS caused by chronic pancreatitis.1
To the top

Videos

WallFlex™ Biliary RX Stents for Benign Indication

Deployment Procedure Animation

This animation highlights the design and deployment procedure for the Fully Covered WallFlex Biliary RX Stent.

Watch Video ›

 

 

 

 

 

Clinical Information

Learn About WallFlex Biliary RX Stent Trials ›



Product Information

Product Brochure ›

Features, benefits, images and clinical references.



Stent Placement Guide ›

Illustrates step-by-step stent deployment procedure.



 

Solutions Services Center

Ordering Information

Find product ordering details including descriptions, sizes, and order numbers.

To see our full product line, view our catalog »

Find Images

Select from more than 150 of our product, fluoroscopy, or endoscopy images to use in your presentation.

Search and download images »

Contact Us

Need help? Have a question?
We're here to help.

Please contact us »

Value Beyond Our Technologies

We offer products and value-added services that enhance outcomes and reduce the cost of patient care.

View our total value approach »

* The Fully Covered WallFlex™ Biliary RX Stent is CE Marked (and registered/approved in other OUS regions) for use in the treatment of benign biliary strictures. Please refer to your Boston Scientific representative to check product registrations and/or availability in your country.

Note: Use of the WallFlex Biliary RX Fully Covered Stent for the treatment of benign strictures of stenosis has not been cleared for use in the United States

1 Stent Removability and Mid-Term Stricture Resolution after Multi-Month Metal Stenting of Benign Biliary Strictures: Interim Report from an International Prospective Trial in 187 Patients, Guido Costamagna et al, DDW 2013 abstract #Su1430.

Warning: The safety and effectiveness of biliary metal stents for use in the vascular system has not been established.


Please note that access to certain information on the following pages is intended for healthcare professionals.

 

The Information is for use only in countries with applicable health authority product registrations. The information on this Site is provided for informational purposes only and is not intended or recommended as a substitute for professional medical advice or for diagnosis purposes. Please refer to your Boston Scientific representative to check product registration and/or availability in your country.

 

Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. CAUTION: Federal Law (USA) restricts these devices to sale by or on the order of a physician. Refer to package insert provided with the product for complete Indications for Use, Contraindications, Warnings, Precautions, and Adverse Events prior to using this product.

WallFlex is a registered or unregistered trademark of Boston Scientific Corporation or its affiliates.

 

ENDO-184021-AA Oct 2013

TRUSTe European Safe Harbor certification